Premature ovarian insufficiency: the need for evidence on the effectiveness of hormonal therapy

References

• Coulam CB, Adamson SC, Annegers JF. Incidence of premature ovarian failure. Obstet Gynecol. 1986;67(4):604–606.
   PubMed Web of Science ®Google Scholar
• Golezar S, Tehrani FR, Khazaei S, et al. The global prevalence of primary ovarian insufficiency and early menopause: a meta-analysis. Climacteric. 2019;22(4):403–411.
   PubMed Web of Science ®Google Scholar
• Liao KLM, Wood N, Conway GS. Premature menopause and psychological well-being. J Psychosom Obstet Gynaecol. 2000;21(3):167–174.
   PubMed Web of Science ®Google Scholar
• Popat VB, Calis KA, Vanderhoof VH, et al. Bone mineral density in estrogen-deficient young women. J Clin Endocrinol Metab. 2009;94(7):2277–2283.
   PubMed Web of Science ®Google Scholar
• Conway GS, Kaltsas G, Patel A, et al. Characterization of idiopathic premature ovarian failure. Fertil Steril. 1996;65(2):337–341.
   PubMed Web of Science ®Google Scholar
• Sullivan SD, Lehman A, Thomas F, et al. Effects of self-reported age at nonsurgical menopause on time to first fracture and bone mineral density in the Women’s Health Initiative Observational Study. Menopause. 2015;22(10):1035–1044.
   PubMed Web of Science ®Google Scholar
• Rivera CM, Grossardt BR, Rhodes DJ, et al. Increased cardiovascular mortality after early bilateral oophorectomy. Menopause. 2009;16(1):15–23.
   PubMed Web of Science ®Google Scholar
• Hu FB, Grodstein F, Hennekens CH, et al. Age at natural menopause and risk of cardiovascular disease. Arch Intern Med. 1999;159(10):1061–1066.
   PubMedGoogle Scholar
• Rocca WA, Bower JH, Maraganore DM, et al. Increased risk of Parkinsonism in women who underwent oophorectomy before menopause. Neurology. 2008;70(3):200–209.
   PubMed Web of Science ®Google Scholar
• Bove R, Secor E, Chibnik LB, et al. Age at surgical menopause influences cognitive decline and Alzheimer pathology in older women. Neurology. 2014;82(3):222–229.
   PubMed Web of Science ®Google Scholar
• Rocca WA, Grossardt BR, de Andrade M, et al. Survival patterns after oophorectomy in premenopausal women: a population-based cohort study. Lancet Oncol. 2006;7(10):821–828.
   PubMed Web of Science ®Google Scholar
• Ossewaarde ME, Bots ML, Verbeek AL, et al. Age at menopause, cause-specific mortality and total life expectancy. Epidemiology. 2005;16(4):556–562.
   PubMed Web of Science ®Google Scholar
• van der Schouw YT, van der Graaf Y, Steyerberg EW, et al. Age at menopause as a risk factor for cardiovascular mortality. Lancet. 1996;347(9003):714–718.
   PubMed Web of Science ®Google Scholar
• Baber RJ, Panay N, Fenton A. 2016 IMS Recommendations on women’s midlife health and menopause hormone therapy. Climacteric. 2016;19(2):109–150.
   PubMed Web of Science ®Google Scholar
• Webber L, Davies M, Anderson R, et al. ESHRE Guideline: management of women with premature ovarian insufficiency. Hum Reprod. 2016;31(5):926–937.
   PubMed Web of Science ®Google Scholar
• Vujovic S, Brincat M, Erel T, et al. EMAS position statement: managing women with premature ovarian failure. Maturitas. 2010;67(1):91–93.
   PubMed Web of Science ®Google Scholar
• Menopause: diagnosis and management NICE guideline [NG23]: National Institute of Health and Clinical Excellence; 2015. [cited Dec 2019]. Available from: https://www.nice.org.uk/guidance/ng23/chapter/recommendations-for-research#5-premature-ovarian-insufficiency.
   Google Scholar
• The British Menopause Society consensus statement on the management of women with premature ovarian insufficiency. British Menopause Society; April 2017; [cited 2021 Mar 12]. Available from: https://thebms.org.uk/publications/consensus-statements/premature-ovarian-insufficiency/.
   Google Scholar
• Gravholt CH, Andersen NH, Conway GS, et al. Clinical practice guidelines for the care of girls and women with Turner syndrome: proceedings from the 2016 Cincinnati International Turner Syndrome Meeting. Eur J Endocrinol. 2017;177:G1–G70.
   PubMed Web of Science ®Google Scholar
• van Kasteren YM, Schoemaker J. Premature ovarian failure: a systematic review on therapeutic interventions to restore ovarian function and achieve pregnancy. Hum Reprod Update. 1999;5(5):483–492.
   PubMed Web of Science ®Google Scholar
• Fraison E, Crawford G, Casper G, et al. Pregnancy following diagnosis of premature ovarian insufficiency: a systematic review. Reprod Biomed Online. 2019;39(3):467–476.
   PubMed Web of Science ®Google Scholar
• Webber L, Anderson RA, Davies M, et al. HRT for women with premature ovarian insufficiency: a comprehensive review. Hum Reprod Open. 2017;2017(2):hox007
   PubMedGoogle Scholar
• Cauley JA, Robbins J, Chen Z, et al. Effects of estrogen plus progestin on risk of fracture and bone mineral density: the Women’s Health Initiative randomized trial. JAMA. 2003;290(13):1729–1738.
   PubMed Web of Science ®Google Scholar
• Burgos N, Cintron D, Latortue-Albino P, et al. Estrogen-based hormone therapy in women with primary ovarian insufficiency: a systematic review. Endocrine. 2017;58(3):413–425.
   PubMed Web of Science ®Google Scholar
• Cintron D, Rodriguez-Gutierrez R, Serrano V, et al. Effect of estrogen replacement therapy on bone and cardiovascular outcomes in women with Turner syndrome: a systematic review and meta-analysis. Endocrine. 2017;55(2):366–375.
   PubMed Web of Science ®Google Scholar
• Prior JC, Vigna YM, Wark JD, et al. Premenopausal ovariectomy-related bone loss: a randomized, double-blind, one-year trial of conjugated estrogen or medroxyprogesterone acetate. J Bone Miner Res. 1997;12(11):1851–1863.
   PubMed Web of Science ®Google Scholar
• Crofton PM, Evans N, Bath LE, et al. Physiological versus standard sex steroid replacement in young women with premature ovarian failure: effects on bone mass acquisition and turnover. Clin Endocrinol. 2010;73(6):707–714.
   PubMed Web of Science ®Google Scholar
• Cartwright B, Robinson J, Seed PT, et al. Hormone replacement therapy versus the combined oral contraceptive pill in premature ovarian failure: a randomized controlled trial of the effects on bone mineral density. J Clin Endocrinol Metab. 2016;101(9):3497–3505.
   PubMed Web of Science ®Google Scholar
• Langrish JP, Mills NL, Bath LE, et al. Cardiovascular effects of physiological and standard sex steroid replacement regimens in premature ovarian failure. Hypertension. 2009;53(5):805–811.
   PubMed Web of Science ®Google Scholar
• Guttmann H, Weiner Z, Nikolski E, et al. Choosing an oestrogen replacement therapy in young adult women with Turner syndrome. Clin Endocrinol. 2001;54(2):159–164.
   PubMed Web of Science ®Google Scholar
• Mittal M, Savvas M, Narvekar N, et al. A cross-sectional national questionnaire survey assessing the clinical attitudes of members of the British Menopause Society to the management of women with premature ovarian insufficiency. Post Reprod Health. 2014;20(3):90–97.
   PubMedGoogle Scholar
• Panay N, Anderson RA, Nappi RE, et al. Premature ovarian insufficiency: an International Menopause Society White Paper. Climacteric. 2020;23(5):426–446.
   PubMed Web of Science ®Google Scholar
• Alzubaidi NH, Chapin HL, Vanderhoof VH, et al. Meeting the needs of young women with secondary amenorrhea and spontaneous premature ovarian failure. Obstet Gynecol. 2002;99:720–725.
   PubMed Web of Science ®Google Scholar
• Cartwright B, Holloway D, Grace J, et al. A service evaluation of women attending the menopause/premature ovarian failure clinic of a tertiary referral centre. J Obstet Gynaecol. 2012;32(4):357–361.
   PubMedGoogle Scholar
• Moretto de Oliveria MR, Cristiane da Silva C, Kurokawa CS, et al. Bone mineral density in healthy female adolescents according to age, bone age and pubertal breast stage. Open Orthop J. 2011;5:324–330.
   PubMedGoogle Scholar
• The British Menopause Society Tool for Clinicians. HRT – practical prescribing [Internet]. British Menopause Society; July 2020; [cited 2021 Mar 12]. Available from: https://thebms.org.uk/wp-content/uploads/2020/07/03-BMS-TfC-HRT-Practical-Prescribing-JULY2020-01E.pdf.
   Google Scholar
• Davies MC, Hall ML, Jacobs HS. Bone mineral loss in young women with amenorrhoea. BMJ. 1990;301(6755):790–793.
   PubMed Web of Science ®Google Scholar
• Hergenroeder AC, Smith EO, Shypailo R, et al. Bone mineral changes in young women with hypothalamic amenorrhea treated with oral contraceptives, medroxyprogesterone, or placebo over 12 months. Am J Obstet Gynecol. 1997;176(5):1017–1025.
   PubMed Web of Science ®Google Scholar
• Gulekli B, Davies MC, Jacobs HS. Effect of treatment on established osteoporosis in young women with amenorrhoea. Clin Endocrinol. 1994;41(3):275–281.
   PubMed Web of Science ®Google Scholar
• Iliodromiti S, Wang W, Lumsden MA, et al. Variation in menopausal vasomotor symptoms outcomes in clinical trials: a systematic review. BJOG. 2020;127(3):320–333.
   PubMed Web of Science ®Google Scholar
• Lewis JE, Hilditch JR, Wong CJ. Further psychometric property development of the Menopause-Specific Quality of Life questionnaire and development of a modified version, MENQOL-Intervention questionnaire. Maturitas. 2005;50(3):209–221.
   PubMed Web of Science ®Google Scholar
• Thirlaway K, Fallowfield L, Cuzick J. The Sexual Activity Questionnaire: a measure of women’s sexual functioning. Qual Life Res. 1996;5(1):81–90.
   PubMed Web of Science ®Google Scholar
• Reilly MC, Zbrozek AS, Dukes EM. The validity and reproducibility of a work productivity and activity impairment instrument. Pharmacoeconomics. 1993;4(5):353–365.
   PubMed Web of Science ®Google Scholar